Novo Nordisk A/S (NONOF)
40.32
-1.18
(-2.84%)
USD |
OTCM |
Apr 29, 15:51
Novo Nordisk Market Cap : 178.79B for April 29, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 760.27B |
| Hims & Hers Health, Inc. | 5.995B |
| Genmab A/S | 16.08B |
| Ascendis Pharma A/S | 13.61B |
Market Cap Related Metrics
| PE Ratio | 11.63 |
| PS Ratio | 3.840 |
| PEG Ratio | 2.058 |
| Price to Book Value | 5.860 |
| Price to Free Cash Flow | 39.74 |
| Price | 40.32 |
| Earnings Yield | 8.60% |
| PEGY Ratio | 1.162 |
| Operating PE Ratio | 9.325 |
| Normalized PE Ratio | 11.63 |